SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 59 filers reported holding SAVARA INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,731 | – | 1,200 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 42 | -70.4% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 142 | -22.8% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 184 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 184 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 184 | -10.7% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 206 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 206 | -2.8% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 212 | -41.8% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 364 | +156.3% | 0.00% | – |
| Q1 2016 | $1,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |